SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Dec-21 4:06 PM View: | Elicio Therapeutics, Inc. (ELTX) | 14-Dec-21 | Market Sale (Planned) | 451 | $2.42 | $1,090.11 | (1%) 30.85K to 30.4K | 3% |
16-Nov-21 4:09 PM View: | Elicio Therapeutics, Inc. (ELTX) | 15-Nov-21 | Market Sale (Planned) | 433 | $4.40 | $1,905.20 | (1%) 31.28K to 30.85K | 4% |
15-Oct-21 4:10 PM View: | Elicio Therapeutics, Inc. (ELTX) | 14-Oct-21 | Market Sale (Planned) | 430 | $8.65 | $3,719.50 | (1%) 31.71K to 31.28K | (< 1%) |
15-Sep-21 4:31 PM View: | Elicio Therapeutics, Inc. (ELTX) | 14-Sep-21 | Market Sale (Planned) | 430 | $10.64 | $4,575.20 | (1%) 32.14K to 31.71K | (< 1%) |
22-Jul-21 6:06 PM View: | Elicio Therapeutics, Inc. (ELTX) | 21-Jul-21 | Market Sale (Planned) | 432 | $10.94 | $4,726.08 | (1%) 33.02K to 32.59K | (6%) |
15-Jul-21 4:08 PM View: | Elicio Therapeutics, Inc. (ELTX) | 14-Jul-21 | Market Sale (Planned) | 431 | $11.01 | $4,745.31 | (1%) 33.02K to 32.59K | 3% |
16-Jun-21 4:06 PM View: | Elicio Therapeutics, Inc. (ELTX) | 14-Jun-21 | Market Sale (Planned) | 427 | $13.27 | $5,666.29 | (1%) 33.45K to 33.02K | < 1% |
18-May-21 4:04 PM View: | Elicio Therapeutics, Inc. (ELTX) | 14-May-21 | Market Sale (Planned) | 440 | $13.92 | $6,124.80 | (1%) 33.89K to 33.45K | < 1% |
15-Apr-21 4:05 PM View: | Elicio Therapeutics, Inc. (ELTX) | 15-Apr-21 | Market Sale | 399 | $15.01 | $5,988.99 | (1%) 34.29K to 33.89K | (< 1%) |
16-Mar-21 4:11 PM View: | Elicio Therapeutics, Inc. (ELTX) | 13-Mar-21 | Market Sale | 499 | $20.45 | $10,204.60 | (1%) 34.78K to 34.29K | (2%) |
17-Feb-21 8:10 PM View: | Elicio Therapeutics, Inc. (ELTX) | 13-Feb-21 | Market Sale | 457 | $19.54 | $8,929.78 | (1%) 35.24K to 34.78K | (2%) |
21-Jun-19 5:38 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Jun-19 | Market Sale | 940 | $5.35 | $5,029.00 | (1%) 64.05K to 63.11K | (53%) |
10-Apr-19 4:33 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 08-Apr-19 | Grant | 30,000 | -- | -- | 95% 31.61K to 61.61K | |
21-Mar-19 4:39 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-19 | Market Sale | 1,792 | $7.99 | $14,318.10 | (5%) 33.4K to 31.61K | (3%) |
21-Dec-18 4:47 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Dec-18 | Market Sale | 425 | $7.52 | $3,196.00 | (1%) 33.83K to 33.4K | (9%) |
22-Jun-18 4:50 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Jun-18 | Market Sale | 1,002 | $25.48 | $25,531.00 | (3%) 34.8K to 33.79K | 68% |
22-Mar-18 5:56 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Mar-18 | Market Sale | 982 | $25.89 | $25,424.00 | (3%) 35.11K to 34.13K | 68% |
09-Mar-18 8:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 06-Mar-18 | Grant | 6,250 | -- | -- | 22% 28.86K to 35.11K | |
21-Dec-17 4:43 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Dec-17 | Market Sale | 440 | $32.30 | $14,212.00 | (2%) 29.3K to 28.86K | 75% |
22-Jun-17 5:05 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Jun-17 | Market Sale | 1,041 | $17.53 | $18,253.70 | (4%) 29.5K to 28.45K | 53% |
20-Jan-17 6:15 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Jan-17 | Grant | 11,250 | -- | -- | 71% 15.94K to 27.19K | |
08-Nov-16 4:33 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 07-Nov-16 | Grant | 4,687 | -- | -- | 42% 11.25K to 15.94K | |
23-May-16 8:19 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 06-May-16 | Grant | 11,250 | -- | -- | 100% 0 to 11.25K | |
17-Mar-15 5:37 PM View: | Medivation, Inc. (MDVN) | 16-Mar-15 | Market Sale | 1,390 | $130.92 | $181,979.00 | (11%) 12.48K to 11.09K | 38% |
02-Mar-15 9:16 PM View: | Medivation, Inc. (MDVN) | 02-Mar-15 | Option Exercise | 2,000 | $47.48 | $94,960.00 | 16% 12.48K to 14.48K | |
02-Mar-15 9:16 PM View: | Medivation, Inc. (MDVN) | 02-Mar-15 | Market Option Sale (Planned) | 2,000 | $122.00 | $244,000.00 | (14%) 14.48K to 12.48K | 33% |
27-Feb-15 4:56 PM View: | Medivation, Inc. (MDVN) | 26-Feb-15 | Option Exercise | 2,000 | $47.48 | $94,960.00 | 16% 12.48K to 14.48K | |
27-Feb-15 4:56 PM View: | Medivation, Inc. (MDVN) | 26-Feb-15 | Market Option Sale (Planned) | 2,000 | $119.29 | $238,590.00 | (14%) 14.48K to 12.48K | 32% |
27-Feb-15 4:56 PM View: | Medivation, Inc. (MDVN) | 26-Feb-15 | Market Sale (Planned) | 1,089 | $119.29 | $129,912.00 | (9%) 12.48K to 11.39K | 32% |
11-Feb-15 4:58 PM View: | Medivation, Inc. (MDVN) | 09-Feb-15 | Grant | 3,500 | -- | -- | 39% 8.98K to 12.48K | |
06-Feb-15 7:03 PM View: | Medivation, Inc. (MDVN) | 04-Feb-15 | Market Sale (Planned) | 610 | $100.85 | $61,518.70 | (6%) 9.59K to 8.98K | 19% |
04-Dec-14 4:54 PM View: | Medivation, Inc. (MDVN) | 03-Dec-14 | Market Sale | 910 | $113.00 | $102,830.00 | (9%) 10.5K to 9.59K | 28% |
06-Feb-14 5:20 PM View: | Medivation, Inc. (MDVN) | 04-Feb-14 | Grant | 4,500 | -- | -- | 75% 6.0K to 10.5K | |
23-Jan-14 7:23 PM View: | Medivation, Inc. (MDVN) | 21-Jan-14 | Option Exercise | 14,000 | $47.48 | $664,720.00 | (41%) 34.0K to 20.0K | |
23-Jan-14 7:23 PM View: | Medivation, Inc. (MDVN) | 21-Jan-14 | Market Sale (Planned) | 14,000 | $76.28 | $1,067,950.00 | (70%) 20.0K to 6.0K | (7%) |